Delivery Order HHSN272201500007I-75N93021F00001

Award Date 12/15/20
Potential Completion Date 12/14/21
Potential Value $114K
Ultimate Awardee
Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost Plus Fixed Fee
Place of Performance
Hinckley, OH 44233, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
3
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This contract was awarded by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases to Icon Government And Public Health Solutions, Inc., a global provider of outsourced clinical trial and research services. The $111,477.00 contract is a delivery order under the Therapeutics Against Infectious Diseases Phase 1 indefinite-delivery, indefinite-quantity (IDIQ) master contract, which enables streamlined ordering of clinical...
This is a cost-plus-fixed-fee delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services (HHS), to Icon Government And Public Health Solutions, Inc. The $102,610.29 order supports NIAID's Phase 1 Clinical Trial Unit for Therapeutics Against Infectious Diseases program, which conducts early-stage clinical trials of investigational products. The contract is part of a larger $545 million NIAID...
This is a delivery order awarded by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases to Icon Government And Public Health Solutions, Inc. for a Phase I clinical trial unit to support development of therapeutics against infectious diseases. The contract has a potential value of $117,402.00 and is a Cost Plus Fixed Fee contract type. Icon Government And Public Health Solutions, Inc. is a global provider of outsourced...
This is a $214,395 delivery order awarded by the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Icon Government And Public Health Solutions, Inc. for Phase 1 clinical trial support services to develop therapeutics against infectious diseases. The award is under the Therapeutics Against Infectious Diseases Phase 1 indefinite delivery/indefinite quantity (IDIQ) contract, which has a potential total value of $1,715,715.70. Icon Government And...
This is a delivery order awarded by the Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases to Icon Government And Public Health Solutions, Inc. The order, valued at $203,215, is for the contractor to provide clinical research management and conduct a Phase 1 clinical trial unit to evaluate therapeutics against infectious diseases. This order is part of a larger 5-year indefinite delivery/indefinite quantity contract...
This is a delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services (HHS). The contract, with a ceiling value of $174,002.53, was awarded to Icon Government And Public Health Solutions, Inc., a for-profit organization, to provide overall administrative and support activities for NIAID's Scientific and Technical Information Coordination and Tracking Group (STI CTG). This includes...
Icon Government and Public Health Solutions, Inc. was awarded a $119,681 delivery order against the Therapeutics Against Infectious Diseases Phase 1 master indefinite delivery/indefinite quantity contract held with the National Institutes of Health National Institute of Allergy and Infectious Diseases. This delivery order, with a potential value of $48,905.35 and period of performance through February 2024, provides for a Phase 1 Clinical Trial Unit for Therapeutics Against Infectious Diseases...
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services (HHS), to Icon Government And Public Health Solutions, Inc., a foreign-owned for-profit organization. The $252,853.28 cost-plus-fixed-fee delivery order is for overall administrative and support activities, including procedures to identify, discuss, and develop scientific concepts, for the Scientific and Technical...
This federal contract award was made by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services (HHS), to Icon Government And Public Health Solutions, Inc. The $80,487.41 fixed-price level of effort purchase order is for laboratory testing services. The award is not associated with a set-aside. Icon Government And Public Health Solutions, Inc. is a global provider of outsourced clinical research and development services...
This is a task order awarded under the Early Phase Clinical Trial Units (EPCTU) indefinite delivery/indefinite quantity (IDIQ) contract, which is managed by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services (HHS). The task order, valued at $2,021,154, covers activities defined under two task areas of the IDIQ contract: Phase I healthy volunteer studies (Task Area C) and Phase I special population studies (Task Area D). The...

This contract was awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Icon Government And Public Health Solutions, Inc., a for-profit organization. The $113,678.00 contract is a delivery order under the "Therapeutics Against Infectious Diseases Phase 1" indefinite delivery/indefinite quantity (IDIQ) contract vehicle, which enables streamlined ordering of clinical trial and medical product development services in support of public health and biodefense missions. The work is for a Phase 1 clinical trial unit focused on evaluating therapeutics against infectious diseases. This contract does not have a set-aside designation.

Generated 3/24/24, 4:20 AM